# Xenon Pharmaceuticals Inc. (XENE) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$373M |
| 2024 | -$279M |
| 2023 | -$214M |
| 2022 | -$129M |
| 2021 | -$79M |
| 2020 | -$31M |
| 2019 | -$43M |
| 2017 | -$33M |
| 2016 | -$25M |
| 2015 | -$9M |
| 2014 | $11M |
| 2013 | $10M |
| 2012 | -$3M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$112M |
| 2025-09-30 | -$96M |
| 2025-06-30 | -$94M |
| 2025-03-31 | -$73M |
| 2024-09-30 | -$74M |
| 2024-06-30 | -$69M |
| 2024-03-31 | -$59M |
| 2022-09-30 | -$38M |
| 2022-06-30 | -$30M |
| 2022-03-31 | -$17M |
| 2021-09-30 | -$16M |
| 2021-06-30 | -$22M |
| 2021-03-31 | -$16M |
| 2020-09-30 | -$10M |
| 2020-06-30 | -$646,000 |
| 2020-03-31 | -$8M |
| 2019-09-30 | -$9M |
| 2017-09-30 | -$9M |
| 2017-06-30 | -$8M |
| 2017-03-31 | -$8M |
| 2016-09-30 | -$7M |
| 2016-06-30 | -$6M |
| 2016-03-31 | -$6M |
| 2015-09-30 | -$820,000 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/XENE/operating-income)